At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 200 enrolled
Drug / intervention
Methadone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse
In Brief
A Phase 1 clinical trial evaluating Methadone and Contingency Management for Opioid Dependence and Cocaine Abuse. Completed, enrolled 200 participants.
Detailed Summary
The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Dependence, Cocaine Abuse
Countries--
Collaborators--
Timeline
Phase 1CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1999
First PostedFeb 2006
Primary CompletionJun 2006
Study CompletionAug 2006
TodayJul 2026
First PostedFeb 15, 2006
Enrollment StartJun 1, 1999
Primary CompletionJun 1, 2006
Study CompletionAug 1, 2006
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 20.4 years ago
Interventions
Methadonedrug
Contingency Managementbehavioral